Rising Stone (XPAR:ALRIS) Research & Development: €0.00 Mil (TTM As of Jun. 2025)


XPAR:ALRIS Rising Stone SA XPAR:ALRIS
13 GF Score
Price €47.00
! 3 Warning Signs
View Full Analysis

What is Rising Stone Research & Development?

Rising Stone XPAR:ALRIS -1.05% 13 Research & Development is €0.00 Mil as of Jun. 2025. GuruFocus rates XPAR:ALRIS with a GF Score™ of 13/100. The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Rising Stone's Research & Development for the six months ended in Jun. 2025 was €0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2025 was €0.00 Mil.

Rising Stone  (XPAR:ALRIS) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Rising Stone Research & Development Related Terms

Rising Stone Research & Development Historical Data

* Premium members only.

The historical data trend for Rising Stone's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rising Stone Research & Development Chart

Rising Stone Annual Data
Trend Dec23 Dec24
Research & Development
0.00 0.00

Rising Stone Semi-Annual Data
Dec23 Jun24 Dec24 Jun25
Research & Development 0.00 0.00 0.00 0.00
XPAR:ALRIS
13GF Score
Rising Stone SA XPAR:ALRIS
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rising Stone Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.00 Mil mean?
Rising Stone (XPAR:ALRIS) has a Research & Development of €0.00 Mil as of Jun. 2025. Research and development expense is the total cost for research and development activities. View historical data on Rising Stone and its competitors.
Is Rising Stone's Research & Development too high?
Rising Stone's current Research & Development is €0.00 Mil. Overall, Rising Stone has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Rising Stone's Research & Development compare to competitors?
Rising Stone's Research & Development of €0.00 Mil can be compared against companies in the Real Estate industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Real Estate company?
A good Research & Development depends on the Real Estate industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Rising Stone and its competitors. Rising Stone's current Research & Development is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rising Stone stock overvalued right now?
Rising Stone (XPAR:ALRIS) has a current Research & Development of €0.00 Mil. The current Research & Development is €0.00 Mil. Rising Stone's overall GF Score™ is 13/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Rising Stone (XPAR:ALRIS), the current Research & Development is €0.00 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Rising Stone Business Description

Other Exchanges J0O:Germany
Address 89 Boulevard de Courcelles, Paris, FRA, 75008
Rising Stone SA is a property designer and developer specializing in the development of mountain chalets and residential properties. Its properties include Fleur des Alpes, Chalet Annapurna, The Chalet des Pistes, The Yeti, Genepi, Isba, Village de l'Oree and Les Grands Chalets des Pistes.
13GF Score

Get the complete analysis for XPAR:ALRIS

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€47.00
Price